98420-50-9Relevant academic research and scientific papers
PHENOXYPROPANOL DERIVATIVES AND THEIR USE IN TREATING CARDIAC AND CARDIOVASCULAR DISEASES
-
Page/Page column 56-57, (2012/02/01)
A compound of formula I-0, and its pharmaceutically acceptable salt or salts and physiologically hydrolysable derivatives in free form or salt form: wherein Z1 is C1-C4 linear or branched alkyl or alkenyl; R4 is selected from unsubstituted and substituted C3-C8 cycloalkyl, C1-C8 linear or branched alkyl, C2-5 alkenyl, C6-C10 heteroaryl or aryl, or C3-C8 heterocyclyl which may be part unsaturated, and combinations thereof; is linear C2-3 alkylene,; X1 is selected from NH and O; X2 is selected from unsaturated C and unsaturated S; and X3 is selected from NH and CH2; or one of X1 and X3 is a single bond; or X1 is O and X2 and X3 together are a single bond; and R7 is selected from oxo, F, Cl, Br, CN, NH2, NR92, NO2, CF3, OR9, COR9, OCOR9, COOR9, NR9COR9, CONR92 SO2NR92, NR9SO2R9; and R8 is selected from C1-5 alkyl, C1-5 alkoxyl, C2-5 alkenyl or alkynyl, C6-10) aryl and C3-8 cycloalkyl and combinations thereof, which may be unsubstituted or f urther substituted by one or more F, Cl, Br, CN, NH2, NR32, NO2, CF3; and R9 is selected from H and a group R8 as hereinbefore defined; n7 and n8 and the sum thereof are independently selected from zero and the whole number integer 1 to 4; processes for the preparation thereof, compositions and uses.
PTERIDINES AND THEIR USE AS AGROCHEMICALS
-
, (2011/04/14)
The present disclosure relates to 1- or 2-(4-(aryloxy)-phenyl)ethylamino-, oxy- or sulfanyl)pteridines and 1- or 2-(4-(heteroaryloxy)-phenyl)ethylamino-, oxy- or sulfanyl)pteridines and their use as agrochemicals and animal health products.
PTERIDINES AND THEIR USE AS AGROCHEMICALS
-
Page/Page column 23, (2011/04/14)
The present disclosure relates to 1- or 2-(4-(aryloxy)-phenyl)ethylamino-, oxy- or sulfanyl)pteridines and 1- or 2-(4-(heteroaryloxy)-phenyl)ethylamino-, oxy- or sulfanyl)pteridines and their use as agrochemicals and animal health products.
Phenylethylamine derivatives and their use in the treatment of melanoma
-
, (2008/06/13)
Novel mono- and dihydroxy phenylethylamine derivatives useful in treating melanoma are provided having the formulae (Ia, Ib or Ic). In the above formulae, Ra is hydrogen or —COORb, Rb is hydrogen or C1-6 alkyl;
Melanocyte-directed enzyme prodrug therapy (MDEPT): Development of second generation prodrugs for targeted treatment of malignant melanoma
Jordan, Allan M.,Khan, Tariq H.,Malkin, Hugh,Osborn, Helen M.I.,Photiou, Andrew,Riley, Patrick A.
, p. 1549 - 1558 (2007/10/03)
Evaluation of second generation prodrugs for MDEPT, by oximetry, has highlighted structural properties that are advantageous and disadvantageous for efficient oxidation using mushroom tyrosinase. In particular, a sterically undemanding prodrug bis-(2-chlo
Selective β3-Adrenergic Agonists of Brown Adipose Tissue and Thermogenesis. 1. ethoxy>phenoxy>acetates
Howe, Ralph,Rao, Balbir S.,Holloway, Brian R.,Stribling, Donald
, p. 1751 - 1759 (2007/10/02)
The ester methyl ethoxy>phenoxy>acetate (8) has been identified as the most interesting member of a series of selective β3-adrenergic agonists of brown adipose tissue and thermogenesis in the rat.In vivo
Mechanistic Studies on Dopamine β-Monooxygenase Catalysis: N-Dealkylation and Mechanism-Based Inhibition by Benzylic-Nitrogen-Containing Compounds. Evidence for a Single-Electron-Transfer Mechanism
Wimalasena, Kandatege,May, Sheldon W.
, p. 4036 - 4046 (2007/10/02)
Dopamine β-monooxygenase (DBM) readily catalyzes oxidative N-dealkylation of N-phenylethylenediamine (PEDA) and N-methyl-N-phenylethylenediamine (N-MePEDA) with the reaction characteriscics expected for a monooxygenase-catalyzed process.The products of this reaction have been quantitatively identified as aniline (or N-methylaniline for N-MePEDA) and 2-aminoacetaldehyde, the latter compound being successfully trapped by using NaBH4 reduction followed by N-succinimidyl p-nitriphenylacetate (SNPA) derivatization, and identified by HPLC and mass spectroscopy.In contrast, either analogues of PEDA, i.e. phenyl 2-aminoethyl ether (PAEE) and its p-hydroxy derivative (p-OHPAEE), as well as 2-phenoxycycloprpylamine are not substrates but are competitive inhibitors.Furthermore, 2-methyl-2-anilino-1-aminoethane (β-MePEDA) did not exhibit measurable substrate activity with DBM, in contrast to the excellent substrate activity of the sulfur analogue of β-MePEDA, 2-methyl-2-(phenylthio)-1-aminoethane (β-MePAES).DBM is inactivated during the N-dealkylation reaction in a time- and concentration-dependent manner, a phenomenon that has not, to our knowledge, been observed for any other oxygenase-catalyzed N-dealkylation reaction.Both PEDA and N-MePEDA, as well as β-MePEDA, inactivate DBM under turnover conditions.The inactivation exhibited pseudo-first-order saturable kinetics and expected protection by the DBM substrate, tyramine.No reappearance of enzyme activity was observed after extensive dialysis.Radioactive labeling experiments with ring-tritiated PEDA showed incorporation of nondialyzable radioactivity into DBM in the expected amount, consistent with covalent attachment of a reactive species derivd from PEDA to the DBM active site during enzyme inactivation.Although aniline, N-ethylaniline, N-(2-fluoroethyl)aniline, m- and p-anisidine, p-toluidine, and 5-hydroxyindole were found not to exhibit detectable DBM substrate activity, all of these inactivated the enzyme under turnover conditions.The isotope effect on partition ratio measured for dideuteriated PEDA was found to be a reflection of an isotope effect on Vmax and not on kinact.Our results provide a strong support for the conclusion that the initial nitrogen cation radical species is responsible for enzyme inactivation.Results with ring-deuteriated and ring-tritiated PEDA revealed that the amount of radioactivity incorporated into covalently inactivated DBM by ring-tritiated PEDA is in agreement with that expected for covalent attachment of the para carbon to the protein.An 18O labeling study was carried out to test for oxygen rebound into the aminoacetaldehyde product, and results demonstrated that the aldehyde oxygen of enzymatically produced 2-aminoacetaldehyde exchanges very rapidly with solvent water, in agreement with literature reports.On the basis ...
